About: http://webisa.webdatacommons.org/48802106

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	If the study was rejected, the reasons for disapproval, the IRB's interpretation of the risk of PrEP, and other barriers will be examined.
http://www.w3.org/ns/prov#wasQuotedFrom	clinicaltrials.gov